During the last session, Vanda Pharmaceuticals Inc (NASDAQ:VNDA)’s traded shares were 1.46 million, with the beta value of the company hitting 0.74. At the end of the trading day, the stock’s price was $4.56, reflecting an intraday loss of -1.51% or -$0.07. The 52-week high for the VNDA share is $7.00, that puts it down -53.51 from that peak though still a striking 27.63% gain since the share price plummeted to a 52-week low of $3.30. The company’s market capitalization is $262.38M, and the average trade volume was 2.34 million shares over the past three months.
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) trade information
Vanda Pharmaceuticals Inc (VNDA) registered a -1.51% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.51% in intraday trading to $4.56, hitting a weekly high. The stock’s 5-day price performance is -12.98%, and it has moved by 17.83% in 30 days. Based on these gigs, the overall price performance for the year is -27.16%.
Vanda Pharmaceuticals Inc (VNDA) estimates and forecasts
Statistics show that Vanda Pharmaceuticals Inc has underperformed its competitors in share price, compared to the industry in which it operates. Vanda Pharmaceuticals Inc (VNDA) shares have gone up 7.55% during the last six months, with a year-to-date growth rate less than the industry average at -250.00% against 12.90. In the rating firms’ projections, revenue will increase 1.00% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 48.5M as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 47.5M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -37.98%.
VNDA Dividends
Vanda Pharmaceuticals Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
